NCT02032043View on ClinicalTrials.gov

Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis for Ivory Coast (DOLF-Ivory Coast)

CompletedOBSERVATIONAL

Enrollment

14,457

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

December 4, 2017

Study Completion Date

December 4, 2017

Conditions

Lymphatic FilariasisOnchocerciasisSoil Transmitted Helminth (STH) Infections

Interventions

DRUG

Annual versus Semiannual Albendazole plus Ivermectin MDA

Annual or semiannual Albendazole plus Ivermectin, administered by the Ivorian Ministry of Health.

Trial Locations (1)

Unknown

Ivory Coast National Program Against Schistosomiasis, Geohelminths and Filariasis, Abidjan

All Listed Sponsors

lead

Washington University School of Medicine

OTHER

NCT02032043 - Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis for Ivory Coast (DOLF-Ivory Coast) | Biotech Hunter | Biotech Hunter